Global Product Supply

It is LEO Pharma's goal to establish the most efficient and most professional Global Product Supply set-up to support the sales of our products ensuring the best quality and a rapid delivery of the LEO products to the customers at a reasonable cost. 

To deliver this, the Global Product Supply organisation is committed to continuous improvements within customer service, production costs, product quality and compliance. The pharmaceutical manufacturing plants are subject to international rules of Good Manufacturing Practice (GMP) and quality assurance. Plants involved in supply to the US are approved by the US Federal Drug Administration (FDA). 

More than 950 employees work in our five production plants situated in Denmark, France, and Ireland;